Nuclear Transport — The Ran Cycle

Core Explanation

The Nuclear Pore Complex (NPC)

The NPC is one of the largest protein assemblies in the cell (~120 MDa in vertebrates), built from ~30 distinct nucleoporin proteins (nups) in multiple copies, totaling ~500–1,000 polypeptide chains. It spans both leaflets of the nuclear envelope, forming an aqueous channel with eightfold rotational symmetry.

FG-nucleoporins are a specialized subset of nups that line the central channel. They contain long, intrinsically disordered regions rich in phenylalanine-glycine (FG) repeats. These FG-repeat domains extend into the channel and form a selective permeability barrier: molecules smaller than ~40 kDa (or ~5 nm diameter) diffuse freely, while larger molecules require active, receptor-mediated transport. The FG repeats are thought to function through a combination of hydrophobic interactions and entropic exclusion — they form a dynamic, gel-like mesh that large cargo cannot penetrate without specific binding to transport receptors that can "dissolve" through the FG network.

The Importin/Exportin Family (Karyopherins)

Nuclear transport receptors (NTRs), collectively called karyopherins, are a family of ~20 proteins in humans that shuttle cargo across the NPC. They all bind FG repeats, allowing them to traverse the NPC barrier.

• Importins (e.g., importin-α, importin-β, transportin): Bind cargo in the cytoplasm (low Ran-GTP) and release it in the nucleus (high Ran-GTP).
• Exportins (e.g., CRM1/exportin-1, CAS): Bind cargo in the nucleus in a Ran-GTP-dependent ternary complex and release it in the cytoplasm after Ran-GTP hydrolysis.

Cargo Recognition: NLS and NES

Nuclear Localization Signals (NLS): The classical NLS (cNLS) comes in two flavors — monopartite (a single cluster of basic residues, e.g., the SV40 large T-antigen NLS: PKKKRKV) and bipartite (two clusters of basic residues separated by a ~10-residue spacer, e.g., nucleoplasmin NLS). Importin-α recognizes the NLS through its armadillo-repeat domain. Importin-β binds importin-α and mediates NPC traversal via FG-repeat interactions. Some cargo (e.g., HIV Rev, ribosomal proteins) bypass importin-α entirely and bind importin-β or transportin directly through non-classical NLS sequences.

Nuclear Export Signals (NES): The best-characterized NES is a leucine-rich sequence (~10 residues with conserved leucines at positions 1, 4, 7, and 10 in a helix). CRM1 (exportin-1) recognizes NES-containing cargo only when bound to Ran-GTP. The hydrophobic face of the NES helix fits into a hydrophobic groove on CRM1.

Molecular Components

Step-by-Step Nuclear Import

1. Cargo recognition (cytoplasm): A cargo protein exposes its NLS. Importin-α binds the NLS. Importin-β binds importin-α, forming the import complex.
2. NPC docking: Importin-β interacts with FG repeats at the cytoplasmic filaments of the NPC.
3. Translocation: The import complex "surfs" through the FG-repeat mesh by iterative binding and release of FG repeats. The entropic cost is paid by the favorable free energy of importin–FG interactions. No ATP or GTP is consumed during transit itself.
4. Cargo release (nucleoplasm): Inside the nucleus, Ran-GTP is abundant. Ran-GTP binds importin-β at a site that allosterically displaces importin-α's IBB (importin-β-binding) domain, dissociating the complex. The cargo is released.
5. Recycling: Importin-β–Ran-GTP returns to the cytoplasm (FG-repeat surfing). Importin-α is exported by CAS–Ran-GTP. In the cytoplasm, RanGAP + RanBP1 stimulate Ran-GTP hydrolysis → Ran-GDP, releasing both importins for another cycle.

Step-by-Step Nuclear Export

1. Cargo recognition (nucleus): CRM1 binds both the NES-containing cargo and Ran-GTP simultaneously. Ran-GTP binding induces a conformational change in CRM1 that creates the NES-binding groove. The ternary complex (cargo–CRM1–Ran-GTP) is the export-competent form.
2. Translocation: CRM1 interacts with FG repeats, carrying the complex through the NPC.
3. Cargo release (cytoplasm): RanGAP + RanBP1/RanBP2 stimulate Ran-GTP hydrolysis → Ran-GDP. This destabilizes the ternary complex. CRM1 releases both cargo and Ran-GDP.
4. Recycling: CRM1 re-enters the nucleus without cargo. Ran-GDP is imported by NTF2 to be recharged by RCC1.

The Ran-GTP Gradient: The Engine of Directionality

The asymmetric distribution of Ran's two regulatory proteins creates the gradient:

• RCC1 (RanGEF) is bound to chromatin (via histone H2A/H2B interaction) and is exclusively nuclear. It catalyzes GDP → GTP exchange on Ran, maintaining high nuclear Ran-GTP (~high µM range).
• RanGAP1 is cytoplasmic (and also concentrated at the cytoplasmic filaments of the NPC via SUMOylation-dependent binding to RanBP2/Nup358). It stimulates Ran's intrinsic GTPase activity by ~10⁵-fold, ensuring that any Ran-GTP reaching the cytoplasm is rapidly hydrolyzed to Ran-GDP.

The result: Ran-GTP is high in the nucleus, low in the cytoplasm. Importins bind cargo where Ran-GTP is low and release where it is high. Exportins bind cargo + Ran-GTP where Ran-GTP is high and release where it is low. The gradient itself is maintained by: (1) NTF2-mediated import of Ran-GDP, (2) RCC1 charging in the nucleus, and (3) continuous Ran-GTP export on exportin complexes followed by cytoplasmic hydrolysis.

Key insight: GTP hydrolysis is not consumed at the pore. Transport across the NPC is not directly coupled to nucleotide hydrolysis. The Ran cycle provides directionality by making cargo binding/release thermodynamically favorable in the correct compartment. Each complete import–export cycle consumes one GTP (Ran-GTP → Ran-GDP + Pi).

Regulation

• NLS/NES masking: Phosphorylation near an NLS or NES can mask or unmask the signal, controlling transport. The transcription factor NF-κB is held in the cytoplasm by IκB, which masks its NLS. Upon IκB phosphorylation and degradation, the NLS is exposed and NF-κB enters the nucleus.
• Calcium signaling: The transcription factor NFAT is phosphorylated and cytoplasmic under resting conditions. When intracellular Ca²⁺ rises, calcineurin dephosphorylates NFAT, exposing its NLS for import. Re-phosphorylation by nuclear kinases exposes an NES for export. The immunosuppressants cyclosporin A and FK506 block this by inhibiting calcineurin.
• Nuclear retention: Some nuclear proteins lack a nuclear export signal and are too large for passive diffusion — they are retained by binding to nuclear structures (chromatin, lamins), even though they could theoretically be exported.

Disease and Clinical Connections

• Primary biliary cirrhosis (PBC): Autoantibodies against nuclear pore proteins (gp210, p62) are diagnostic markers. The mechanism by which nuclear pore autoantigens drive autoimmune bile duct destruction is incompletely understood but highlights the immunological exposure of NPC components.
• Triple-A syndrome (Allgrove syndrome): Mutations in ALADIN, a nucleoporin component of the NPC, cause achalasia, alacrima, and adrenal insufficiency. Nuclear import of DNA repair proteins may be impaired.
• Viral exploitation: HIV Rev protein contains a potent NES that directs unspliced viral RNA out of the nucleus through CRM1. Influenza virus uses its own NLS-bearing proteins to import the viral ribonucleoprotein. The drug selinexor (a CRM1 inhibitor) is FDA-approved for multiple myeloma — it traps tumor suppressor proteins in the nucleus by blocking their export.
• Cancer: Mutations that create or expose NLS signals in oncoproteins, or that delete NES signals from tumor suppressors, drive nuclear accumulation of proliferation drivers. p53 is cytoplasmically sequestered in some cancers through NLS masking or hyperactive CRM1-mediated export.

High-Yield Summary

• NPC: ~30 nups, 8-fold symmetry, FG-repeat barrier; <40 kDa passive, >40 kDa receptor-mediated.
• Importins: cargo in cytoplasm (low Ran-GTP) → release in nucleus (Ran-GTP binding displaces cargo).
• Exportins: cargo + Ran-GTP in nucleus → Ran-GTP hydrolysis in cytoplasm → release.
• Ran gradient: RCC1 (GEF) = nuclear, RanGAP (GAP) = cytoplasmic. This is the sole source of directionality.
• GTP is hydrolyzed in the cytoplasm, not at the pore. The NPC itself does not consume energy during transit.
• Regulation by signal masking (phosphorylation, protein binding, Ca²⁺/calcineurin).
• CRM1 inhibitor selinexor = cancer therapeutic. Viral NES/NLS motifs are potential drug targets.

Practice Questions

1. You microinject a non-hydrolyzable GTP analog (GTPγS) into the cytoplasm of cultured cells. Predict the effect on (a) nuclear import and (b) nuclear export of NES-bearing cargo. Explain.

Answer: (a) Nuclear import is inhibited. Importin-β that has delivered cargo to the nucleus binds Ran-GTP (or Ran-GTPγS) and returns to the cytoplasm. In the cytoplasm, Ran-GTPγS cannot be hydrolyzed by RanGAP, so importin-β remains trapped in a Ran-GTPγS-bound state and cannot bind new importin-α/cargo complexes. (b) Nuclear export initially accelerates (abnormally stable Ran-GTPγS promotes CRM1–cargo–Ran complex formation in the nucleus), but then stalls because CRM1 is trapped in the cytoplasm after one round, unable to release Ran-GTPγS for reimport. Ultimately, both import and export arrest as Ran and transport receptors become locked in dead-end complexes.

2. A mutant form of RCC1 (RanGEF) is engineered that localizes to the cytoplasm instead of the nucleus. What happens to the Ran gradient and nuclear transport?

Answer: The Ran gradient collapses or reverses. With RCC1 in the cytoplasm, Ran-GTP is generated where it should be absent. Import cargo cannot be released in the nucleus (insufficient Ran-GTP to displace importin-β), and export cargo cannot be loaded in the nucleus (insufficient Ran-GTP for CRM1–cargo complex formation). The cell effectively loses compartment identity between nucleus and cytoplasm. This would be lethal.

3. A patient presents with a tumor in which the tumor suppressor p53 is found exclusively in the cytoplasm despite being wild-type. Propose two molecular mechanisms that could explain this, and suggest a therapeutic intervention.

Answer: Mechanism 1: Hyperactive CRM1-mediated export — overexpression or constitutive activation of CRM1 drives excessive p53 export. Mechanism 2: NLS masking — a binding partner (e.g., MDM2, or a mutant Parc protein) occludes the p53 NLS, preventing importin-α recognition. Both result in cytoplasmic p53 that cannot activate pro-apoptotic target genes. Therapeutic intervention: Selinexor (CRM1 inhibitor) would block mechanism 1 by preventing p53 export, allowing nuclear accumulation. For mechanism 2, drugs that disrupt the masking interaction (e.g., nutlin, which blocks MDM2–p53 binding) could expose the NLS.

Common Misconceptions

"GTP hydrolysis powers cargo movement through the pore." No. Translocation through the NPC is passive diffusion of the receptor–cargo complex through the FG-repeat mesh. GTP hydrolysis occurs in the cytoplasm and only drives the cargo-binding/release cycle.

"Ran is a motor protein." No. Ran is a small GTPase switch. It provides directionality by creating a binding/release cycle, not motive force.

"The nuclear pore is a simple hole." No. The NPC is a highly selective, dynamically gated transport machine. FG-nups create an entropic barrier that excludes inert macromolecules while allowing receptor-bound cargo to pass. It is arguably the most sophisticated protein-based filter in nature.